Psychopharmacol Bull 2021 Jun;51(3):27-37
Caselli, MD, PhD Student, Gasparini, MD, PhD Student, Ielmini, MD, PhD Student, Lucca, MD, PhD Student, Amorosi, MD, Poloni, MD, PhD, Researcher, Callegari, MD, PhD, Associate Professor, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy.
Nowadays, mental illness can no longer be considered as a mere list of symptoms corresponding to localized brain dysfunctions but rather as a disturbance of the patient's subjectivity. Thus, a solid, qualitative study of patients' subjectivity could represent a useful tool in the complex evaluation of efficacy of pharmacotherapy in schizophrenic persons. In this perspective, authors performed a phenomenological oriented investigation on 49 patients, diagnosed with schizophrenia spectrum disorder, who were receiving long-acting injectable (LAI) antipsychotic therapy. Read More